Ascendis Pharma A/S (ASND) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 250.66M | 245.18M | 213.63M | 158.04M | 100.95M | 173.92M | 57.83M | 36M | 95.89M | 137.7M | 48.03M | 47.39M |
| Revenue Growth % | 148.29% | 40.98% | 269.4% | 339.04% | 5.28% | 26.3% | 20.4% | -24.04% | 185.49% | 501.42% | 214.15% | 669.37% |
| Cost of Goods Sold | 21.62M | 27.2M | 22.35M | 31.45M | 17.52M | 14.02M | 11.2M | 11.46M | 7.57M | 19.46M | 7.39M | 12.93M |
| COGS % of Revenue | 8.63% | 11.09% | 10.46% | 19.9% | 17.35% | 8.06% | 19.37% | 31.85% | 7.89% | 14.13% | 15.38% | 27.28% |
| Gross Profit | 229.03M | 217.98M | 191.28M | 126.6M | 83.44M | 159.89M | 46.63M | 24.53M | 88.33M | 118.25M | 40.65M | 34.46M |
| Gross Margin % | 91.37% | 88.91% | 89.54% | 80.1% | 82.65% | 91.94% | 80.63% | 68.15% | 92.11% | 85.87% | 84.62% | 72.72% |
| Gross Profit Growth % | 174.5% | 36.33% | 310.19% | 416.03% | -5.53% | 35.22% | 14.73% | -28.82% | 204.91% | 564.9% | 198.93% | 579.23% |
| Operating Expenses | 203.81M | 208.18M | 180.28M | 179.55M | 187.65M | 159.51M | 143.38M | 157.79M | 137.47M | 154.86M | 175.05M | 175.3M |
| OpEx % of Revenue | 81.31% | 84.91% | 84.39% | 113.61% | 185.88% | 91.72% | 247.91% | 438.33% | 143.36% | 112.46% | 364.44% | 369.89% |
| Selling, General & Admin | 146.18M | 133.2M | 111.69M | 105.71M | 95.65M | 78.78M | 68.13M | 74.31M | 66.78M | 63.98M | 62.51M | 70.28M |
| SG&A % of Revenue | 58.32% | 54.33% | 52.28% | 66.89% | 94.74% | 45.3% | 117.8% | 206.43% | 69.64% | 46.46% | 130.14% | 148.29% |
| Research & Development | 57.63M | 74.98M | 66.88M | 71.99M | 86.6M | 79.3M | 73.54M | 83.48M | 70.69M | 90.88M | 111.44M | 105.02M |
| R&D % of Revenue | 22.99% | 30.58% | 31.31% | 45.55% | 85.78% | 45.59% | 127.17% | 231.9% | 73.71% | 66% | 232% | 221.6% |
| Other Operating Expenses | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 | 1000K | 0 |
| Operating Income | 25.22M | 9.8M | 11M | -52.95M | -104.21M | 383K | -96.74M | -133.26M | -49.15M | -36.61M | -134.41M | -140.84M |
| Operating Margin % | 10.06% | 4% | 5.15% | -33.5% | -103.23% | 0.22% | -167.28% | -370.18% | -51.25% | -26.59% | -279.82% | -297.17% |
| Operating Income Growth % | 124.2% | 2459.58% | 111.37% | 60.26% | -112.05% | 101.05% | 28.02% | 5.38% | 65.8% | 75.16% | 6.99% | 0.74% |
| EBITDA | 29.51M | 14.58M | 15.02M | -48.64M | -99.67M | 4.86M | -95.04M | -131.24M | -44.64M | -31.76M | -129.53M | -136.2M |
| EBITDA Margin % | 11.77% | 5.95% | 7.03% | -30.78% | -98.73% | 2.79% | -164.34% | -364.58% | -46.55% | -23.07% | -269.65% | -287.39% |
| EBITDA Growth % | 129.61% | 200.16% | 115.8% | 62.94% | -123.26% | 115.3% | 26.62% | 3.64% | 67.92% | 78.24% | 7.39% | 0.9% |
| D&A (Non-Cash Add-back) | 4.29M | 4.78M | 4.02M | 4.31M | 4.54M | 4.47M | 1.7M | 2.02M | 4.5M | 4.85M | 4.88M | 4.63M |
| EBIT | 25.22M | 9.8M | -57.37M | -1.99M | -48.78M | -42.37M | -72.83M | -89.53M | -51.37M | -72.66M | -137.06M | -112.53M |
| Net Interest Income | -63.77M | -37.57M | -16.39M | 22.04M | -15.93M | -9.92M | 2.93M | 29.43M | -73.59M | -68.55M | -20.38M | 26.43M |
| Interest Income | 4.59M | 23.83M | 3.33M | 55.06M | 28.85M | -66.55M | 28.28M | 49.05M | 3.58M | 0 | 4.14M | 35.76M |
| Interest Expense | 68.36M | 61.4M | 19.72M | 33.02M | 44.79M | -56.63M | 25.35M | 19.62M | 77.16M | 68.55M | 24.52M | 9.33M |
| Other Income/Expense | -74.19M | -36.26M | -68.37M | 17.94M | 10.65M | -37.77M | -1.44M | 24.11M | -79.38M | -44.48M | -27.17M | 18.98M |
| Pretax Income | -48.97M | -26.45M | -57.37M | -35.01M | -93.56M | -37.38M | -98.18M | -109.15M | -128.53M | -81.09M | -161.58M | -121.86M |
| Pretax Margin % | -19.54% | -10.79% | -26.86% | -22.15% | -92.68% | -21.5% | -169.76% | -303.21% | -134.03% | -58.89% | -336.38% | -257.13% |
| Income Tax | -688.66M | 6.79M | 3.62M | 3.85M | 1.06M | 1.08M | 1.02M | 229K | 2.51M | 5.79M | 645K | -429K |
| Effective Tax Rate % | 1406.31% | -25.68% | -6.3% | -10.99% | -1.13% | -2.9% | -1.04% | -0.21% | -1.95% | -7.14% | -0.4% | 0.35% |
| Net Income | 639.69M | -33.25M | -60.99M | -38.85M | -94.63M | -38.47M | -99.2M | -109.38M | -131.03M | -86.88M | -162.22M | -121.43M |
| Net Margin % | 255.21% | -13.56% | -28.55% | -24.58% | -93.73% | -22.12% | -171.52% | -303.85% | -136.65% | -63.09% | -337.73% | -256.23% |
| Net Income Growth % | 776.02% | 13.57% | 38.52% | 64.48% | 27.79% | 55.72% | 38.85% | 9.93% | -18.14% | 58.11% | 3.98% | -49.33% |
| Net Income (Continuing) | 639.69M | -33.25M | -60.99M | -38.85M | -94.63M | -38.47M | -99.2M | -109.38M | -131.03M | -86.88M | -162.22M | -121.43M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 9.91 | -0.54 | -1.00 | -0.82 | -1.58 | -0.64 | -1.69 | -1.91 | -2.30 | -1.53 | -2.88 | -2.16 |
| EPS Growth % | 727.22% | 15.63% | 40.83% | 57.07% | 31.3% | 58.17% | 41.32% | 11.57% | -16.16% | 58.65% | 4.95% | -47.95% |
| EPS (Basic) | 10.37 | -0.54 | -1.00 | -0.64 | -1.58 | -0.64 | -1.69 | -1.91 | -2.30 | -1.53 | -2.88 | -2.16 |
| Diluted Shares Outstanding | 64.52M | 61.38M | 60.99M | 63.91M | 60.02M | 59.79M | 58.57M | 57.35M | 56.88M | 56.61M | 56.27M | 56.22M |
| Basic Shares Outstanding | 61.68M | 61.38M | 60.99M | 60.45M | 60.02M | 59.79M | 58.57M | 57.35M | 56.88M | 56.61M | 56.27M | 56.22M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |